Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

In the background green and pink tablets, on the right in the foreground a portrait photo of Prof. Clara Lehmann.
© NIAID; MedizinFotoKöln

New guidelines unveil advanced strategies for HIV treatment and prevention

On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of

Electron micrograph of a hepatitis C virus particle.
© Center for the Study of Hepatitis C, The Rockefeller University/via Wikimedia Commons

Vaccine research: new hope in the fight against hepatitis C

The development of an effective vaccine against the hepatitis C virus has been an enormous challenge for decades due to the high genetic diversity of the virus. The research team led by DZIF scientist

Portrait fotos of Philipp Schommers and Alexander Simonis
© Uniklinik Köln/MedizinFotoKöln/Michael Wodak/Christian Wittke

Walter Siegenthaler Medals in Silver 2024 awarded to two DZIF junior scientists

Two DZIF junior scientists—Prof Philipp Schommers and Dr Alexander Simonis—have been honoured with silver medals by the Walter Siegenthaler Society for their fundamental medical research in the field

Clarivate Image for Highly Cited Researchers 2024
© Clarivate 2024

Eleven DZIF scientists among the “Highly Cited Researchers 2024”

Eleven scientists from the German Center for Infection Research (DZIF) are among the “Highly Cited Researchers 2024”. The ranking, published on 19 November by the company Clarivate Analytics, lists

Tanja Schneider presenting the PHOENIX award
© PHOENIX group

Prof. Tanja Schneider receives PHOENIX Pharmacy Science Award

Prof. Tanja Schneider, Head of the Institute of Pharmaceutical Microbiology at the University Hospital Bonn (UKB) and Deputy Coordinator of the “New Antibiotics” research area at the German Center for

Pseudomonas aeruginosa bacteria in 3D
© CDC/James Archer

An innovative class of antibiotics to combat drug-resistant bacteria

Antibacterial drugs are important for treating infections. However, increasing bacterial resistance to current drugsmaking them ineffective or only partially effectivemeans that new drugs are

Michael Ramharter and his team at the award ceremony
© Michael Ramharter

DZIF tropical medicine specialist receives Memento Research Award 2024

DZIF scientist Michael Ramharter from the Bernhard Nocht Institute for Tropical Medicine in Hamburg and the University Medical Center Hamburg-Eppendorf has received the Memento Research Prize 2024

Banner der WHO zur World AMR Awareness Week 2024
© WHO/WAAW 2024

World AMR Awareness Week 2024, 18-24 November – Educate. Advocate. Act now.

Antimicrobial resistance (AMR) is one of the most urgent challenges facing global health and development. Described as a “creeping pandemic” by the G7 forum of leading economic nations, AMR occurs

Portraits of the three ERC Synergy Grant winners
© Privat, HZI/Krüger, Uni Würzburg/Knote

ERC Synergy Grant: German-French team receives eleven million euros for AI-assisted search for new antibiotics

Professors Ivo Boneca (Institut Pasteur, Paris), Mark Brönstrup (Helmholtz Centre for Infection Research, Braunschweig, and German Center for Infection Research), and Christophe Zimmer (University of

The image shows a highly magnified electron micrograph of several oval, slightly rough Escherichia coli bacterial cells. The colour of the image is a reddish tone. The background is dark and highlights the bacteria.
© HZI

Chemical trick activates antibiotic directly at the pathogen

Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in around 30 percent